The effect of tamoxifen on the genital tract

Autor:	Susan M. Ascher, Sandra A. Polin
Rok vydání:	2008
Předmět:	Oncology Cervix Uteri Review Endometrium Endosonography Medicine skin and connective tissue diseases Radiological and Ultrasound Technology ultrasound Incidence General Medicine Middle Aged Magnetic Resonance Imaging medicine.anatomical_structure Selective estrogen receptor modulator Chemotherapy Adjuvant Chemoprophylaxis Vagina Female Endometrial polyp endometrial hyperplasia hormones hormone substitutes and hormone antagonists medicine.drug MRI Adult medicine.medical_specialty Antineoplastic Agents Hormonal Breast Neoplasms endometrial cystic atrophy Risk Assessment Drug Administration Schedule Breast cancer Internal medicine Humans Radiology Nuclear Medicine and imaging Aged Uterine sarcoma Dose-Response Relationship Drug business.industry Endometrial cancer Ovary medicine.disease Female Urogenital Diseases hysterosonography Tamoxifen adenomyosis business Follow-Up Studies
Zdroj:	Cancer Imaging
ISSN:	1470-7330
Popis:	Tamoxifen is a selective estrogen receptor modulator (SERM) that is widely used in the treatment of patients with breast cancer and for chemoprophylaxis in high risk women. Tamoxifen results in a spectrum of abnormalities involving the genital tract, the most significant being an increased incidence of endometrial cancer and uterine sarcoma. This article reviews the effects of tamoxifen on the genital tract and the strengths and weaknesses of various imaging modalities for evaluating the endometrium.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4eecff65c70e85308329941f94fe223d https://pubmed.ncbi.nlm.nih.gov/18603495 Zobrazit plný text záznamu Full text from SpringerLink